New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

BACKGROUND: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ueda, Youki, Takeda, Midori, Mori, Kyoko, Dansako, Hiromichi, Wakita, Takaji, Kim, Hye-Sook, Sato, Akira, Wataya, Yusuke, Ikeda, Masanori, Kato, Nobuyuki
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3758303/
https://ncbi.nlm.nih.gov/pubmed/24023620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072519
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki